1,186
Views
11
CrossRef citations to date
0
Altmetric
Research Paper

T-cell-specific mTOR deletion in mice ameliorated CD4+ T-cell survival in lethal sepsis induced by severe invasive candidiasis

ORCID Icon, , , &
Pages 892-901 | Received 01 Jul 2019, Accepted 08 Sep 2019, Published online: 31 Oct 2019

References

  • Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015;15(373):1445–1456.
  • Candel FJ, Pazos PC, Ruiz-Camps I, et al. Update on management of invasive candidiasis. Rev Esp Quimioter. 2017;30(6):397–406.
  • Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;;62:e1-50.
  • Spec A, Shindo Y, Burnham CA, et al. T cells from patients with Candida sepsis display a suppressive immunophenotype. Crit Care. 2016;20:15.
  • Guzman JA, Tchokonte R, Sobel JD. Septic shock due to candidemia: outcomes and predictors of shock development. J Clin Med Res. 2011;3:65–71.
  • Li Y, Du M, Chen L, et al. Nosocomial bloodstream infection due to Candida spp. in China: species distribution, clinical features, and outcomes. Mycopathologia. 2016;181(78):485–495.
  • Sam QH, Yew WS, Seneviratne CJ, et al. Immunomodulation as therapy for fungal infection: are we closer? Front Microbiol. 2018. 9.
  • Duggan S, Leonhardt I, Hunniger K, et al. Host response to Candida albicans bloodstream infection and sepsis. Virulence. 2015;6(4):316–326.
  • Ono S, Tsujimoto H, Hiraki S, et al. Mechanisms of sepsis-induced immunosuppression and immunological modification therapies for sepsis. Ann Gastroenterol Surg. 2018;2(5):351–358.
  • Ben-Sahra I, BD M. mTORC1 signaling and the metabolic control of cell growth. Curr Opin Cell Biol. 2017;45:72–82.
  • Mossmann D, Park S, Hall MN. mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat Rev Cancer. 2018;18(12):744–757.
  • Aylett CH, Sauer E, Imseng S, et al. Architecture of human mTOR complex 1. Science. 2015;351(6268):48–52.
  • AR T, Manning BD, Roux PP, et al. Tuberous sclerosis complex gene products, tuberin and hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol. 2003;13:1259–1268.
  • Chi H. Regulation and function of mTOR signalling in T cell fate decisions. Nat Rev Immunol. 2012;12:325–338.
  • Delgoffe GM, Pollizzi KN, Waickman AT, et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol. 2011;12:295–303.
  • Eisenberg-Lerner A, Bialik S, Simon H-U, et al. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ. 2009;16(7):966–975.
  • Qi W, Liu Y, Chen C, et al. The tuberous sclerosis complex–mammalian target of rapamycin pathway maintains the quiescence and survival of naive T cells. J Immunol. 2011;187:1106–1112.
  • O’Brien TF, Gorentla BK, Xie D, et al. Regulation of T cell survival and mitochondrial homeostasis by TSC1. Eur J Immunol. 2011;41(11):3361–3370.
  • Cui N, Su LX, Wang H, et al. mTOR modulates lymphocyte differentiation through T-bet and eomesodermin in response to invasive pulmonary aspergillosis in rats. Chin Med J (Engl). 2016;129(14):1704–1710.
  • Wang H, Xiao Y, Su L, et al. mTOR modulates CD8+ T cell differentiation in mice with invasive pulmonary aspergillosis. Open Life Sci. 2018;13(1):129–136.
  • Deretic V, Saitoh T, Akira S. Autophagy in infection, inflammation and immunity. Nat Rev Immunol. 2013;13(10):722–737.
  • Pua HH, Guo J, Komatsu M, et al. Autophagy is essential for mitochondrial clearance in mature T Lymphocytes1. J Immunol. 2009;182:4046–4055.
  • Oami T, Watanabe E, Hatano M, et al. Suppression of T cell autophagy results in decreased viability and function of T cells through accelerated apoptosis in a Murine Sepsis model. Crit Care Med. 2017;45(1):e77–e85.
  • Lin C-W, Steven L, Hsu C, et al. T-cell autophagy deficiency increases mortality and suppresses immune responses after sepsis. PLoS ONE. 2014;9(7):e102066.
  • Conti HR, Huppler AR, Whibley N, et al. Animal models for candidiasis. Curr Protoc Immunol. 2014;105:19.6.1–17.
  • Lee EKS, Gillrie MR, Li L, et al. Leukotriene B4-mediated neutrophil recruitment causes pulmonary capillaritis during lethal fungal sepsis. Cell Host Microbe. 2018;23(1):121–133.
  • MacCallum DM, Odds FC. Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice. Mycoses. 2005;48(3):151–161.
  • Carreras E, Velasco DAM, Orta-Mascaro M, et al. Discordant susceptibility of inbred C57BL/6 versus outbred CD1 mice to experimental fungal sepsis. Cell Microbiol. 2019;21(5):e12995.
  • Hurtrel B, Lagrange PH, Michel JC. Systemic candidiasis in mice. Ann Immunol. 1980;131:93–104.
  • Shrum B, Anantha RV, Xu SX, et al. A robust scoring system to evaluate sepsis severity in an animal model. BMC Res Notes. 2014;7(1):233.
  • Lee Y-K, Lee J-A. Role of the mammalian ATG8/LC3 family in autophagy: differentialand compensatory roles in the spatiotemporal regulation of autophagy. BMB Rep. 2016;49(8):424–430.
  • Puissant A, Fenouille N, Auberger P. When autophagy meets cancer through p62/SQSTM1. Am J Cancer Res. 2012;2(4):397–413.
  • Katsuragi Y, Ichimura Y, Komatsu M. p62/SQSTM1 functions as a signaling hub and an autophagy adaptor. Febs J. 2015;282(24):4672–4678.
  • Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12(1):1–222.
  • Zhang J, Cui N, Wang H, et al. Invasive fungal disease in Critically Ill patients at high risk: usefulness of lymphocyte subtyping. J Intensive Care Med. 2018;270811397.
  • Green DR, Levine B. To be or not to be? How selective autophagy and cell death govern cell fate. Cell. 2014;157(1):65–75.
  • Anding AL, Baehrecke EH. Autophagy in Cell Life and Cell Death. Curr Top Dev Biol. 2015;114:67–91.
  • Ying L, Zhao G, Wu Y, et al. Mitofusin 2 promotes apoptosis of CD4+T cells by inhibiting autophagy in sepsis. Mediat Inflamm. 2017:2017:1–15.